en
ua
ru
de
pt
es
pl
fr
tr
fi
da
no
sv
en
EGW-NewsDota 2All newsSwedenstrong became a player in the starting lineup of NaVi in Dota 2
Swedenstrong became a player in the starting lineup of NaVi in Dota 2
8872
0
0

Swedenstrong became a player in the starting lineup of NaVi in Dota 2

Natus Vincere have published information on their website and in other media that Georgy 'swedenstrong' Zainalabidov will replace Ilya 'ALOHADANCE' Korbkin in fourth position on a permanent basis. Previously, he joined the team as a substitute player for the duration of the playoff stage of the second round of Dota Pro Circuit Eastern Europe 2021/2022. Despite the fact that the “Born to Win” took 5-6th place in the standings there, the management recognized the player as suitable to cooperate with Georgy on an ongoing basis. Natus Vincere thus managed to keep its place in the first division of the third round of Dota Pro Circuit Eastern Europe 2021/2022. The esportsman has already moved to Serbia and is at the bootcamp with his new teammates.

The next tournament in which NaVi will take part will be the third round of Dota Pro Circuit Eastern Europe 2021/2022, the dates of which are not yet known.

Chicken.gg

Free gems, plus daily, weekly, & monthly boosts!

Chicken.gg
CS:GO
Claim bonus
Farmskins

Sign up now and get 2 FREE CASES + 5$ Bonus

Farmskins
CS:GO
Claim bonus
CSFAIL

EXTRA 10% DEPOSIT BONUS + free 2 spins

CSFAIL
CS:GO
Claim bonus

Georgy 'swedenstrong' Zaynalabidov is a 19-year-old esports player of Russian origin who started his career as a professional Dota 2 player in 2020. For all the time he managed to play in such teams as Excellent Esports, potn9ki, Azimut, Squelch Kommando and NOVA. He is also known for playing under the nickname gunter. In 2 years of playing on the professional Dota 2 scene, swedenstrong earned $3,600.

Updated Natus Vincere Dota 2 roster

  • Alik 'V-Tune' Sparrow
  • Vladimir 'No[o]ne' Minenko
  • Vladislav 'laise' Lais
  • George 'swedenstrong' Zainalabidov
  • Alexey 'Solo' Berezin
Leave comment
Did you like the article?
0
0

Comments

BRING TO TOP
FREE SUBSCRIPTION ON EXCLUSIVE CONTENT
Receive a selection of the most important and up-to-date news in the industry.
*
*Only important news, no spam.
SUBSCRIBE
LATER
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic.
Customize
OK